Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 843

1.

Isolated Abdominal Motor Seizures of Mesial Parietal Origin: Epileptic Belly Dancing?

Lizarraga KJ, Serrano EA, Tornes L, Kanner AM, Lang AE.

Mov Disord Clin Pract. 2019 Apr 19;6(5):396-399. doi: 10.1002/mdc3.12762. eCollection 2019 Jun. No abstract available.

PMID:
31286010
2.

Dancing Dorsal Quadrilaterals-Organic or Functional?-Reply.

Lizarraga KJ, Thompson PD, Lang AE.

JAMA Neurol. 2019 Jul 1. doi: 10.1001/jamaneurol.2019.1720. [Epub ahead of print] No abstract available.

PMID:
31260001
3.

The clinical significance of lower limb tremors.

Rajalingam R, Breen DP, Chen R, Fox S, Kalia LV, Munhoz RP, Slow E, Strafella AP, Lang AE, Fasano A.

Parkinsonism Relat Disord. 2019 Jun 8. pii: S1353-8020(19)30268-8. doi: 10.1016/j.parkreldis.2019.06.007. [Epub ahead of print]

PMID:
31201091
4.

Parkinson's disease in the Western Pacific Region.

Lim SY, Tan AH, Ahmad-Annuar A, Klein C, Tan LCS, Rosales RL, Bhidayasiri R, Wu YR, Shang HF, Evans AH, Pal PK, Hattori N, Tan CT, Jeon B, Tan EK, Lang AE.

Lancet Neurol. 2019 Jun 4. pii: S1474-4422(19)30195-4. doi: 10.1016/S1474-4422(19)30195-4. [Epub ahead of print] Review.

PMID:
31175000
5.

Hiding in Plain Sight: Functional Neurological Disorders in the News.

Popkirov S, Nicholson TR, Bloem BR, Cock HR, Derry CP, Duncan R, Dworetzky BA, Edwards MJ, Espay AJ, Hallett M, Lang AE, Leach JP, Lehn A, McGonigal A, Morgante F, Perez DL, Reuber M, Richardson MP, Smith P, Stamelou M, Tijssen MAJ, Tinazzi M, Carson AJ, Stone J.

J Neuropsychiatry Clin Neurosci. 2019 May 23:appineuropsych19010025. doi: 10.1176/appi.neuropsych.19010025. [Epub ahead of print]

PMID:
31117907
6.

Dystonia and Parkinson's disease: What is the relationship?

Shetty AS, Bhatia KP, Lang AE.

Neurobiol Dis. 2019 May 9. pii: S0969-9961(19)30107-X. doi: 10.1016/j.nbd.2019.05.001. [Epub ahead of print] Review.

PMID:
31078682
7.

Jumping to overcome freezing of gait while turning in Parkinson's disease.

Lizarraga KJ, Gnanamanogaran B, Fasano A, Lang AE.

Parkinsonism Relat Disord. 2019 Apr 30. pii: S1353-8020(19)30216-0. doi: 10.1016/j.parkreldis.2019.04.021. [Epub ahead of print] No abstract available.

PMID:
31076266
8.

Paroxysmal Asymmetric Dystonic Arm Posturing-A Less Recognized but Characteristic Manifestation of ATP1A3-related disease.

Balint B, Stephen CD, Udani V, Sankhla CS, Barad NH, Lang AE, Bhatia KP.

Mov Disord Clin Pract. 2019 Apr 4;6(4):312-315. doi: 10.1002/mdc3.12747. eCollection 2019 Apr.

PMID:
31061839
9.

Isolated lingual myoclonus in an HIV patient.

Ameghino L, Marrodan M, Lang AE, Merello M.

Parkinsonism Relat Disord. 2019 Apr;61:241-244. doi: 10.1016/j.parkreldis.2018.10.020. Epub 2018 Oct 15. No abstract available.

PMID:
31036159
10.

Tremor with congenital mirror movements: evidence of involvement of the primary motor cortex in tremor.

Isayama R, Chen R, Lang AE, Deuschl G, Fasano A.

Eur J Neurol. 2019 Jun;26(6):e66-e67. doi: 10.1111/ene.13901. No abstract available.

PMID:
31034740
11.

The utility of the acromion marker cluster (AMC) in a clinical population.

Lang AE, Kim SY, Milosavljevic S, Dickerson CR.

J Electromyogr Kinesiol. 2019 Apr 15. pii: S1050-6411(18)30483-8. doi: 10.1016/j.jelekin.2019.04.002. [Epub ahead of print]

PMID:
31006518
12.

The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.

Vizcarra JA, Sánchez-Ferro Á, Maetzler W, Marsili L, Zavala L, Lang AE, Martinez-Martin P, Mestre TA, Reilmann R, Hausdorff JM, Dorsey ER, Paul SS, Dexheimer JW, Wissel BD, Fuller RLM, Bonato P, Tan AH, Bloem BR, Kopil C, Daeschler M, Bataille L, Kleiner G, Cedarbaum JM, Klucken J, Merola A, Goetz CG, Stebbins GT, Espay AJ; MDS Technology Task Force and the MDS Rating Scales Program Electronic Development Ad-Hoc Committee.

Mov Disord. 2019 May;34(5):676-681. doi: 10.1002/mds.27673. Epub 2019 Mar 22. No abstract available.

PMID:
30901492
13.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2019 Mar 18. doi: 10.1002/mds.27666. [Epub ahead of print]

PMID:
30884545
14.

Reader response: IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease.

Bally JF, Lang AE.

Neurology. 2019 Mar 12;92(11):544. doi: 10.1212/WNL.0000000000007087. No abstract available.

PMID:
30858247
15.

Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindred.

Balint B, Lang AE.

Parkinsonism Relat Disord. 2019 Feb 19. pii: S1353-8020(19)30070-7. doi: 10.1016/j.parkreldis.2019.02.024. [Epub ahead of print] No abstract available.

PMID:
30858069
16.

Smoldering Multiple Myeloma Associated Leukoencephalopathy Presenting with Holmes Tremor, Ataxia, and Pyramidal Syndrome.

Aquino CC, Connolly B, Lang AE.

Mov Disord Clin Pract. 2018 Jul 19;5(4):433-435. doi: 10.1002/mdc3.12623. eCollection 2018 Jul-Aug. No abstract available.

17.

Successful spinal cord stimulation for severe medication-refractory restless legs syndrome.

De Vloo P, Reddy GD, Rowland N, Sammartino F, Llinas M, Paul D, Murray BJ, Lang AE, Fasano A, Munhoz RP, Kalia SK.

Mov Disord. 2019 Apr;34(4):585-586. doi: 10.1002/mds.27644. Epub 2019 Feb 15. No abstract available.

PMID:
30768799
18.

Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism.

Freitas ME, Alqaraawi A, Lang AE, Liu LWC.

Mov Disord Clin Pract. 2018 Jan 28;5(2):218-220. doi: 10.1002/mdc3.12577. eCollection 2018 Mar-Apr. No abstract available.

19.

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB.

Neurology. 2019 Feb 12;92(7):329-337. doi: 10.1212/WNL.0000000000006926.

PMID:
30745444
20.

Diagnostic delay in Parkinson's disease caused by PRKN mutations.

Ruiz-Lopez M, Freitas ME, Oliveira LM, Munhoz RP, Fox SH, Rohani M, Rogaeva E, Lang AE, Fasano A.

Parkinsonism Relat Disord. 2019 Jan 10. pii: S1353-8020(19)30010-0. doi: 10.1016/j.parkreldis.2019.01.010. [Epub ahead of print]

PMID:
30692050
21.

Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.

Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA; LEAP Study Group.

N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983.

PMID:
30673543
22.

Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes".

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C.

Parkinsonism Relat Disord. 2018 Dec 28. pii: S1353-8020(18)30562-5. doi: 10.1016/j.parkreldis.2018.12.028. [Epub ahead of print] No abstract available.

PMID:
30655161
23.

Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?

Breen DP, Halliday GM, Lang AE.

Mov Disord. 2019 Mar;34(3):307-316. doi: 10.1002/mds.27556. Epub 2019 Jan 17. Review.

PMID:
30653258
24.

ADCK3-related Coenzyme Q10 Deficiency: A Potentially Treatable Genetic Disease.

Chang A, Ruiz-Lopez M, Slow E, Tarnopolsky M, Lang AE, Munhoz RP.

Mov Disord Clin Pract. 2018 Oct 9;5(6):635-639. doi: 10.1002/mdc3.12667. eCollection 2018 Nov-Dec.

PMID:
30637285
25.

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease.

Yilmaz R, Strafella AP, Bernard A, Schulte C, van den Heuvel L, Schneiderhan-Marra N, Knorpp T, Joos TO, Leypoldt F, Geritz J, Hansen C, Heinzel S, Apel A, Gasser T, Lang AE, Berg D, Maetzler W, Marras C.

Front Neurol. 2018 Dec 21;9:1123. doi: 10.3389/fneur.2018.01123. eCollection 2018.

26.
27.

Dancing Dorsal Quadrilaterals: A Novel Peripherally Induced Movement Disorder.

Lizarraga KJ, Thompson PD, Moore HP, Mizraji G, Gershanik OS, Singer C, Lang AE.

JAMA Neurol. 2018 Dec 17. doi: 10.1001/jamaneurol.2018.3948. [Epub ahead of print]

PMID:
30556833
28.

Comment on "Is it Useful to Classify PSP and CBD as Different Disorders?"

Lang AE.

Mov Disord Clin Pract. 2018 Oct 3;5(5):564-565. doi: 10.1002/mdc3.12676. eCollection 2018 Sep-Oct. No abstract available.

PMID:
30515448
29.

Neurostimulation for Functional Neurological Disorder: Evaluating Longitudinal Neurophysiology.

Burke MJ, Isayama R, Jegatheeswaran G, Gunraj C, Feinstein A, Lang AE, Chen R.

Mov Disord Clin Pract. 2018 Oct 1;5(5):561-563. doi: 10.1002/mdc3.12651. eCollection 2018 Sep-Oct. No abstract available.

PMID:
30515447
30.

Successful pallidotomy for post-hyperglycemic hemichorea-ballism.

De Vloo P, Breen DP, Milosevic L, Lee DJ, Dallapiazza RF, Hutchison WD, Lang AE, Lozano AM.

Parkinsonism Relat Disord. 2019 Apr;61:228-230. doi: 10.1016/j.parkreldis.2018.11.023. Epub 2018 Nov 28. No abstract available.

PMID:
30514649
31.

Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway.

Cho SS, Christopher L, Koshimori Y, Li C, Lang AE, Houle S, Strafella AP.

Neurobiol Dis. 2019 Apr;124:176-182. doi: 10.1016/j.nbd.2018.11.022. Epub 2018 Nov 22.

PMID:
30471418
32.

Beta-propeller protein associated neurodegeneration (BPAN); the first report of three patients from Iran with de novo novel mutations.

Rohani M, Fasano A, Akhoundi FH, Haeri G, Lang AE, Rahimi Bidgoli MM, Javanparast L, Zamani B, Shahidi G, Alavi A.

Parkinsonism Relat Disord. 2019 Apr;61:231-233. doi: 10.1016/j.parkreldis.2018.11.012. Epub 2018 Nov 13. No abstract available.

PMID:
30455156
33.

Photorhabdus luminescens Tc toxin is inhibited by the protease inhibitor MG132 and activated by protease cleavage resulting in increased binding to target cells.

Ost GS, Ng'ang'a PN, Lang AE, Aktories K.

Cell Microbiol. 2019 Mar;21(3):e12978. doi: 10.1111/cmi.12978. Epub 2018 Dec 2.

PMID:
30431706
34.

Opsoclonus-myoclonus-encephalopathy induced by cefepime.

Lizarraga KJ, Heros DO, Adams D, Lang AE, Kanner AM.

J Neurol Sci. 2019 Jan 15;396:33-35. doi: 10.1016/j.jns.2018.10.028. Epub 2018 Nov 1. No abstract available.

PMID:
30412900
35.

Soft signs in movement disorders: friends or foes?

Fearon C, Espay AJ, Lang AE, Lynch T, Martino D, Morgante F, Quinn NP, Vidailhet M, Fasano A.

J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):961-962. doi: 10.1136/jnnp-2018-318455. Epub 2018 Nov 8. No abstract available.

PMID:
30409889
36.

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.

Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D.

Mov Disord. 2018 Nov;33(11):1769-1776. doi: 10.1002/mds.27488. Epub 2018 Nov 2.

37.

Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease.

Udow SJ, Hobson DE, Kleiner G, Masellis M, Fox SH, Lang AE, Marras C.

Mov Disord Clin Pract. 2017 Nov 27;5(1):66-74. doi: 10.1002/mdc3.12563. eCollection 2018 Jan-Feb.

38.

Therapeutic trial design for frontotemporal dementia and related disorders.

Desmarais P, Rohrer JD, Nguyen QD, Herrmann N, Stuss DT, Lang AE, Boxer AL, Dickerson BC, Rosen H, van Swieten JC, Meeter LH, Borroni B, Tartaglia MC, Feldman HH, Black SE, Masellis M.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):412-423. doi: 10.1136/jnnp-2018-318603. Epub 2018 Oct 25. Review.

PMID:
30361298
39.

Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.

Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE.

Ann Neurol. 2018 Dec;84(6):797-811. doi: 10.1002/ana.25364. Epub 2018 Nov 30. Review.

PMID:
30357892
40.

Systematic review of movement disorders and oculomotor abnormalities in Whipple's disease.

Bally JF, Méneret A, Roze E, Anderson M, Grabli D, Lang AE.

Mov Disord. 2018 Nov;33(11):1700-1711. doi: 10.1002/mds.27419. Epub 2018 Oct 19. Review.

PMID:
30338868
41.

Investigating Voice as a Biomarker for Leucine-Rich Repeat Kinase 2-Associated Parkinson's Disease.

Arora S, Visanji NP, Mestre TA, Tsanas A, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Lang AE, Little MA, Marras C.

J Parkinsons Dis. 2018;8(4):503-510. doi: 10.3233/JPD-181389.

42.

Ataxia-telangiectasia: A review of movement disorders, clinical features and genotype correlations - Addendum.

Levy A, Lang AE.

Mov Disord. 2018 Aug;33(8):1372. doi: 10.1002/mds.27449. Epub 2018 Jul 30. No abstract available.

PMID:
30230625
43.

Movement disorder society criteria for clinically established early Parkinson's disease.

Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB.

Mov Disord. 2018 Oct;33(10):1643-1646. doi: 10.1002/mds.27431. Epub 2018 Aug 25.

PMID:
30145841
44.

Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice.

Mestre TA, Shamy M, Benedetti F, Lang AE.

Mov Disord. 2018 Aug;33(8):1195-1203. doi: 10.1002/mds.27409. Epub 2018 Aug 25. Review.

PMID:
30145820
45.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D.

Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.

PMID:
30145797
46.

[18 F]AV-1451 binding and postmortem pathology of CBD.

Coakeley S, Ang LC, Jansen GH, Cho SS, Lang AE, Houle S, Kalia LV, Strafella AP.

Mov Disord. 2018 Aug;33(8):1360-1361. doi: 10.1002/mds.27356. Epub 2018 Aug 23. No abstract available.

PMID:
30136331
47.

Workstation configuration and container type influence upper limb posture in grocery bagging.

Lang AE, Maciukiewicz JM, Vidt ME, Grenier SG, Dickerson CR.

Appl Ergon. 2018 Nov;73:206-213. doi: 10.1016/j.apergo.2018.07.012. Epub 2018 Jul 30.

PMID:
30098637
48.

Brain tissue pulsatility is related to clinical features of Parkinson's disease.

Shirzadi Z, Robertson AD, Metcalfe AW, Duff-Canning S, Marras C, Lang AE, Masellis M, MacIntosh BJ.

Neuroimage Clin. 2018 Jul 23;20:222-227. doi: 10.1016/j.nicl.2018.07.017. eCollection 2018.

49.

Reproducibility of data-driven Parkinson's disease subtypes for clinical research.

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C.

Parkinsonism Relat Disord. 2018 Nov;56:102-106. doi: 10.1016/j.parkreldis.2018.07.009. Epub 2018 Jul 20.

PMID:
30056038
50.

The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study.

Varley JA, Webb AJS, Balint B, Fung VSC, Sethi KD, Tijssen MAJ, Lynch T, Mohammad SS, Britton F, Evans M, Hacohen Y, Lin JP, Nardocci N, Granata T, Dale RC, Lim MJ, Bhatia KP, Lang AE, Irani SR.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):724-726. doi: 10.1136/jnnp-2018-318584. Epub 2018 Jul 21. No abstract available.

Supplemental Content

Support Center